Last reviewed · How we verify
Placebo (for baclofen)
Placebo does not have a pharmacological effect.
Placebo does not have a pharmacological effect. Used for Treatment of spasticity.
At a glance
| Generic name | Placebo (for baclofen) |
|---|---|
| Sponsor | Ethypharm |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
A placebo is a dummy treatment that has no active ingredients and is used as a control in clinical trials to compare the effectiveness of a real treatment. It works by providing a psychological effect, such as a perceived improvement in symptoms, due to the patient's expectation of improvement.
Approved indications
- Treatment of spasticity
Common side effects
Key clinical trials
- Baclofen for Children With Rumination Syndrome (PHASE3)
- Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence (PHASE2, PHASE3)
- Multiprofen-CC to Reduce Pain in Hand Arthritis (PHASE3)
- Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty (PHASE3)
- Baclofen for the Treatment of Alcohol Drinkers (PHASE2, PHASE3)
- Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. (PHASE4)
- Effects of Baclofen on Presynaptic Inhibition in Humans (PHASE2)
- FMT for Alcohol Use Disorder in Cirrhotics. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for baclofen) CI brief — competitive landscape report
- Placebo (for baclofen) updates RSS · CI watch RSS
- Ethypharm portfolio CI